Santhera Pharmaceuticals AG Cuts Jobs to Slow Cash Burn

Reuters - Swiss specialty pharmaceutical company Santhera Pharmaceuticals (SANN.S) said it was cutting jobs and stopping in-house drug discovery to preserve cash as it seeks further approvals for its lead drug.